Related references
Note: Only part of the references are listed.Dendritic Cell-Based Immunotherapy for Prostate Cancer
Hanka Jaehnisch et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2010)
Primary Analysis of the Phase II Component of a Phase I/II Dose Intensification Study Using Three-Dimensional Conformal Radiation Therapy and Concurrent Chemotherapy for Patients With Inoperable Non-Small-Cell Lung Cancer: RTOG 0117
Jeffrey D. Bradley et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Second-line systemic therapy and emerging drugs for metastatic transitional-cell carcinoma of the urothelium
Guru Sonpavde et al.
LANCET ONCOLOGY (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Bladder Cancer
James E. Montie et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2009)
History of bacillus Calmette-Guerin and bladder cancer: An immunotherapy success story
Harry W. Herr et al.
JOURNAL OF UROLOGY (2008)
Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells
Venky Ramakrishna et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
Ectopic hCGβ expression by epithelial cancer:: Malignant behaviour, metastasis and inhibition of tumor cell apoptosis
R. K. Iles
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2007)
Overexpression of human chorionic gonadotropin beta genes 3, 5 and 8 in tumor tissue and urinary cells of bladder cancer patients
Kristina Hotakainen et al.
TUMOR BIOLOGY (2007)
Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: A contemporary series from the bladder cancer research consortium
Shahrokh F. Shariat et al.
JOURNAL OF UROLOGY (2006)
Final results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon α-2B for reducing recurrence of superficial bladder cancer
Fadi N. Joudi et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2006)
Recent advances in contraceptive vaccine development: a mini-review
RK Naz et al.
HUMAN REPRODUCTION (2005)
Leveraging the activity of tumor vaccines with cytotoxic chemotherapy
LA Emens et al.
CANCER RESEARCH (2005)
Toll-like, receptor 8-mediated reversal of CD4+ regulatory T cell function
GY Peng et al.
SCIENCE (2005)
Adjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis of individual patient data
AV Bono et al.
EUROPEAN UROLOGY (2005)
Neoadjuvant chemotherapy in invasive bladder cancer:: Update of a systematic review and meta-analysis of individual patient data
H Abol-Enein et al.
EUROPEAN UROLOGY (2005)
A novel human cancer vaccine elicits cellular responses to the tumor-associated antigen, human chorionic gonadotropin β
LZ He et al.
CLINICAL CANCER RESEARCH (2004)
Humoral epitope-spreading following immunization with a HER-2/neu peptide based vaccine in cancer patients
ML Disis et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2004)
Mannose receptor-targeted vaccines
T Keler et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2004)
Serum HCG beta and CA 72-4 are stronger prognostic factors than CEA, CA 19-9 and CA 242 in pancreatic cancer
J Louhimo et al.
ONCOLOGY (2004)
T2a transitional cell carcinoma of the bladder: Longterm experience with intravesical immunoprophylaxis with bacillus Calmette-Guerin
BG Volkmer et al.
JOURNAL OF UROLOGY (2003)
Tumor-associated antigen human chorionic gonadotropin beta contains numerous antigenic determinants recognized by in vitro-induced CD8+ and CD4+ T lymphocytes
V Dangles et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
The free β-subunit of human chorionic gonadotropin as a prognostic factor in renal cell carcinoma
K Hotakainen et al.
BRITISH JOURNAL OF CANCER (2002)
Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients
JP Stein et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Immunotherapy with mannan-MUC1 and IL-12 in MUC1 transgenic mice
CJ Lees et al.
VACCINE (2000)